68559-60-4 Usage
Description
6.7-dihydrothieno[3.2.c]pyridin-4(5H)-one is an organic compound with a unique chemical structure that features a thieno-pyridine ring system. It is characterized by its potential applications in the pharmaceutical industry, particularly as an impurity in the synthesis of certain drugs.
Uses
Used in Pharmaceutical Industry:
6.7-dihydrothieno[3.2.c]pyridin-4(5H)-one is used as an impurity in the preparation of Ticlopidine Hydrochloride (T438325), which is an antithrombotic agent. It serves as a platelet aggregation inhibitor, playing a crucial role in the prevention of blood clot formation and related medical conditions.
In the synthesis of Ticlopidine Hydrochloride, the presence of 6.7-dihydrothieno[3.2.c]pyridin-4(5H)-one as an impurity is significant because it can affect the purity and efficacy of the final product. Therefore, controlling the levels of this impurity is essential for ensuring the safety and effectiveness of the antithrombotic drug.
Check Digit Verification of cas no
The CAS Registry Mumber 68559-60-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,8,5,5 and 9 respectively; the second part has 2 digits, 6 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 68559-60:
(7*6)+(6*8)+(5*5)+(4*5)+(3*9)+(2*6)+(1*0)=174
174 % 10 = 4
So 68559-60-4 is a valid CAS Registry Number.
68559-60-4Relevant articles and documents
IN-FLOW PHOTOOXYGENATION OF AMINOTHIENOPYRIDINONES GENERATES NOVEL PTP4A3 PHOSPHATASE INHIBITORS
-
Paragraph 0092; 00156, (2020/06/05)
The disclosure provides compounds that inhibit protein tyrosine phosphatase, such as protein tyrosine phosphatase 4A3 (PTP4A3). The disclosure also provides pharmaceutical compositions, uses, and methods of using the compounds, such as in the treatment of cancers. (I), wherein X is O or NH.
INHIBITORS OF PTP4A3 FOR THE TREATMENT OF CANCER
-
Page/Page column 24, (2017/01/02)
The invention provides protein tyrosine phosphatase inhibitor compounds, Their pharmaceutical compositions, uses, and methods of use, such as in the treatment of various cancers, and process for making the compounds. Also disclosed is an improved synthesi
17a-HYDROXYLASE/C17,20-LYASE INHIBITORS
-
, (2014/03/21)
The present invention provides compounds of Formula (I), or a pharmaceutically acceptable salt thereof, where R1, R2, R3, R4, R5, R6, A and n are as defined herein. A deuteriated derivative of the compound of Formula (I) is also provided.
